Docetaxel, nedaplatin, and S-1 (DGS) chemotherapy for advanced esophageal carcinoma: a phase I dose-escalation study.

Yoshihiro Tanaka(Kyushu University Hospital), Takao Takahashi(Maruyama Memorial General Hospital), Kazuhiro Yoshida(Kyoto Institute of Technology), Kazuya Yamaguchi(Tokyo Electron (Japan)), Shinji Osada(Gifu University)
PubMed
December 1, 2011
Cited by 16


Related Papers